Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bone Marrow Aspirate Matrix in Knee Osteoarthritis
NCT06238934Phase 3Not yet recruiting
- Sponsor
- Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad
- Start
- Mar 2024
- Primary completion
- Mar 2025
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of bone marrow aspirate in knee osteoarthritis (OA) (3 arms), sponsored by Instituto Nacional de Traumatologia e Ortopedia Jamil Haddad. Primary endpoints: Knee Society Score at 1 year, Western Ontario and McMaster Universities Osteoarthritis Index at 1 year and 1 more. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
bone marrow aspirate
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06238934.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06238934.